nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.113	0.159	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.113	0.159	CbGbCtD
Salmeterol—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0846	0.119	CbGbCtD
Salmeterol—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0813	0.114	CbGbCtD
Salmeterol—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0518	0.0729	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0518	0.0729	CbGbCtD
Salmeterol—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0388	0.0547	CbGbCtD
Salmeterol—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0356	0.0501	CbGbCtD
Salmeterol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0355	0.0499	CbGbCtD
Salmeterol—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0342	0.0482	CbGbCtD
Salmeterol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.033	0.0464	CbGbCtD
Salmeterol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0151	0.0213	CbGbCtD
Salmeterol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0139	0.0195	CbGbCtD
Salmeterol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00947	0.0133	CbGbCtD
Salmeterol—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000851	CcSEcCtD
Salmeterol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000245	0.000847	CcSEcCtD
Salmeterol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000245	0.000847	CcSEcCtD
Salmeterol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000245	0.000846	CcSEcCtD
Salmeterol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000243	0.00084	CcSEcCtD
Salmeterol—Malaise—Etoposide—peripheral nervous system neoplasm	0.000242	0.000837	CcSEcCtD
Salmeterol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.000837	CcSEcCtD
Salmeterol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.00083	CcSEcCtD
Salmeterol—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.00083	CcSEcCtD
Salmeterol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000239	0.000828	CcSEcCtD
Salmeterol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000239	0.000828	CcSEcCtD
Salmeterol—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000239	0.000827	CcSEcCtD
Salmeterol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000239	0.000827	CcSEcCtD
Salmeterol—Infection—Cisplatin—peripheral nervous system neoplasm	0.000238	0.000822	CcSEcCtD
Salmeterol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000238	0.000821	CcSEcCtD
Salmeterol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000236	0.000814	CcSEcCtD
Salmeterol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000236	0.000814	CcSEcCtD
Salmeterol—Rash—Topotecan—peripheral nervous system neoplasm	0.000236	0.000814	CcSEcCtD
Salmeterol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000235	0.000813	CcSEcCtD
Salmeterol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000235	0.000811	CcSEcCtD
Salmeterol—Cough—Etoposide—peripheral nervous system neoplasm	0.000234	0.00081	CcSEcCtD
Salmeterol—Headache—Topotecan—peripheral nervous system neoplasm	0.000234	0.000809	CcSEcCtD
Salmeterol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000234	0.000808	CcSEcCtD
Salmeterol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000234	0.000808	CcSEcCtD
Salmeterol—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000234	0.000807	CcSEcCtD
Salmeterol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000233	0.000807	CcSEcCtD
Salmeterol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000233	0.000807	CcSEcCtD
Salmeterol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000233	0.000806	CcSEcCtD
Salmeterol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000233	0.000804	CcSEcCtD
Salmeterol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000232	0.000803	CcSEcCtD
Salmeterol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000232	0.000802	CcSEcCtD
Salmeterol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000232	0.000802	CcSEcCtD
Salmeterol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000232	0.000802	CcSEcCtD
Salmeterol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000231	0.0008	CcSEcCtD
Salmeterol—Pain—Vincristine—peripheral nervous system neoplasm	0.000231	0.0008	CcSEcCtD
Salmeterol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000231	0.0008	CcSEcCtD
Salmeterol—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.0008	CcSEcCtD
Salmeterol—Rash—Melphalan—peripheral nervous system neoplasm	0.000231	0.000797	CcSEcCtD
Salmeterol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00023	0.000796	CcSEcCtD
Salmeterol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00023	0.000794	CcSEcCtD
Salmeterol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000229	0.00079	CcSEcCtD
Salmeterol—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000789	CcSEcCtD
Salmeterol—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000787	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000227	0.000785	CcSEcCtD
Salmeterol—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000226	0.000781	CcSEcCtD
Salmeterol—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000773	CcSEcCtD
Salmeterol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000223	0.000771	CcSEcCtD
Salmeterol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000223	0.000771	CcSEcCtD
Salmeterol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.000767	CcSEcCtD
Salmeterol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.000767	CcSEcCtD
Salmeterol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000222	0.000767	CcSEcCtD
Salmeterol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000221	0.000765	CcSEcCtD
Salmeterol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00022	0.000761	CcSEcCtD
Salmeterol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00022	0.000761	CcSEcCtD
Salmeterol—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000219	0.000758	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000218	0.000753	CcSEcCtD
Salmeterol—Infection—Etoposide—peripheral nervous system neoplasm	0.000218	0.000753	CcSEcCtD
Salmeterol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000217	0.000751	CcSEcCtD
Salmeterol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000217	0.000751	CcSEcCtD
Salmeterol—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000747	CcSEcCtD
Salmeterol—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000747	CcSEcCtD
Salmeterol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000215	0.000743	CcSEcCtD
Salmeterol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000214	0.000739	CcSEcCtD
Salmeterol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000214	0.000739	CcSEcCtD
Salmeterol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000214	0.000739	CcSEcCtD
Salmeterol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000213	0.000737	CcSEcCtD
Salmeterol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000213	0.000736	CcSEcCtD
Salmeterol—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.00073	CcSEcCtD
Salmeterol—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000718	CcSEcCtD
Salmeterol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000207	0.000716	CcSEcCtD
Salmeterol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.000715	CcSEcCtD
Salmeterol—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000715	CcSEcCtD
Salmeterol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000205	0.000707	CcSEcCtD
Salmeterol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.000696	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000694	CcSEcCtD
Salmeterol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000691	CcSEcCtD
Salmeterol—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000691	CcSEcCtD
Salmeterol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000199	0.000689	CcSEcCtD
Salmeterol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000682	CcSEcCtD
Salmeterol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000197	0.00068	CcSEcCtD
Salmeterol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000195	0.000675	CcSEcCtD
Salmeterol—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000674	CcSEcCtD
Salmeterol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000194	0.000671	CcSEcCtD
Salmeterol—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00067	CcSEcCtD
Salmeterol—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000666	CcSEcCtD
Salmeterol—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000666	CcSEcCtD
Salmeterol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000193	0.000666	CcSEcCtD
Salmeterol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000665	CcSEcCtD
Salmeterol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.000664	CcSEcCtD
Salmeterol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000191	0.00066	CcSEcCtD
Salmeterol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000189	0.000654	CcSEcCtD
Salmeterol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000189	0.000653	CcSEcCtD
Salmeterol—Pain—Etoposide—peripheral nervous system neoplasm	0.000187	0.000648	CcSEcCtD
Salmeterol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000187	0.000648	CcSEcCtD
Salmeterol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000647	CcSEcCtD
Salmeterol—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000647	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000642	CcSEcCtD
Salmeterol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000642	CcSEcCtD
Salmeterol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000185	0.00064	CcSEcCtD
Salmeterol—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000628	CcSEcCtD
Salmeterol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000625	CcSEcCtD
Salmeterol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000181	0.000624	CcSEcCtD
Salmeterol—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000623	CcSEcCtD
Salmeterol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00018	0.000622	CcSEcCtD
Salmeterol—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00062	CcSEcCtD
Salmeterol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000179	0.00062	CcSEcCtD
Salmeterol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000179	0.000618	CcSEcCtD
Salmeterol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000179	0.000617	CcSEcCtD
Salmeterol—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000616	CcSEcCtD
Salmeterol—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000616	CcSEcCtD
Salmeterol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.000612	CcSEcCtD
Salmeterol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.000611	CcSEcCtD
Salmeterol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000176	0.000609	CcSEcCtD
Salmeterol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.000608	CcSEcCtD
Salmeterol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000174	0.000602	CcSEcCtD
Salmeterol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000599	CcSEcCtD
Salmeterol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000173	0.000599	CcSEcCtD
Salmeterol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000173	0.000599	CcSEcCtD
Salmeterol—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000599	CcSEcCtD
Salmeterol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000599	CcSEcCtD
Salmeterol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000172	0.000595	CcSEcCtD
Salmeterol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000172	0.000593	CcSEcCtD
Salmeterol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000593	CcSEcCtD
Salmeterol—Rash—Vincristine—peripheral nervous system neoplasm	0.000171	0.00059	CcSEcCtD
Salmeterol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00017	0.000589	CcSEcCtD
Salmeterol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000587	CcSEcCtD
Salmeterol—Headache—Vincristine—peripheral nervous system neoplasm	0.00017	0.000586	CcSEcCtD
Salmeterol—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000581	CcSEcCtD
Salmeterol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000578	CcSEcCtD
Salmeterol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.000577	CcSEcCtD
Salmeterol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000164	0.000566	CcSEcCtD
Salmeterol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000162	0.000558	CcSEcCtD
Salmeterol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000161	0.000556	CcSEcCtD
Salmeterol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000555	CcSEcCtD
Salmeterol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000555	CcSEcCtD
Salmeterol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000549	CcSEcCtD
Salmeterol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000157	0.000544	CcSEcCtD
Salmeterol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000544	CcSEcCtD
Salmeterol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00054	CcSEcCtD
Salmeterol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000539	CcSEcCtD
Salmeterol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000534	CcSEcCtD
Salmeterol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000152	0.000526	CcSEcCtD
Salmeterol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000524	CcSEcCtD
Salmeterol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000521	CcSEcCtD
Salmeterol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000521	CcSEcCtD
Salmeterol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00052	CcSEcCtD
Salmeterol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00015	0.000518	CcSEcCtD
Salmeterol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000513	CcSEcCtD
Salmeterol—Tension—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000511	CcSEcCtD
Salmeterol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000505	CcSEcCtD
Salmeterol—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000503	CcSEcCtD
Salmeterol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000145	0.000501	CcSEcCtD
Salmeterol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000145	0.0005	CcSEcCtD
Salmeterol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.0005	CcSEcCtD
Salmeterol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000498	CcSEcCtD
Salmeterol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000494	CcSEcCtD
Salmeterol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000491	CcSEcCtD
Salmeterol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000485	CcSEcCtD
Salmeterol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000483	CcSEcCtD
Salmeterol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000139	0.000482	CcSEcCtD
Salmeterol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000481	CcSEcCtD
Salmeterol—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000478	CcSEcCtD
Salmeterol—Rash—Etoposide—peripheral nervous system neoplasm	0.000138	0.000478	CcSEcCtD
Salmeterol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000138	0.000477	CcSEcCtD
Salmeterol—Headache—Etoposide—peripheral nervous system neoplasm	0.000137	0.000475	CcSEcCtD
Salmeterol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000472	CcSEcCtD
Salmeterol—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000469	CcSEcCtD
Salmeterol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000468	CcSEcCtD
Salmeterol—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000466	CcSEcCtD
Salmeterol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000463	CcSEcCtD
Salmeterol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00046	CcSEcCtD
Salmeterol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000454	CcSEcCtD
Salmeterol—Nausea—Etoposide—peripheral nervous system neoplasm	0.00013	0.00045	CcSEcCtD
Salmeterol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000449	CcSEcCtD
Salmeterol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000447	CcSEcCtD
Salmeterol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000443	CcSEcCtD
Salmeterol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000443	CcSEcCtD
Salmeterol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000443	CcSEcCtD
Salmeterol—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000442	CcSEcCtD
Salmeterol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000442	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00044	CcSEcCtD
Salmeterol—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000438	CcSEcCtD
Salmeterol—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000434	CcSEcCtD
Salmeterol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000433	CcSEcCtD
Salmeterol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000426	CcSEcCtD
Salmeterol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000425	CcSEcCtD
Salmeterol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000425	CcSEcCtD
Salmeterol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000422	CcSEcCtD
Salmeterol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00042	CcSEcCtD
Salmeterol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000416	CcSEcCtD
Salmeterol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000416	CcSEcCtD
Salmeterol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000415	CcSEcCtD
Salmeterol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000413	CcSEcCtD
Salmeterol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00041	CcSEcCtD
Salmeterol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00041	CcSEcCtD
Salmeterol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00041	CcSEcCtD
Salmeterol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000409	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000407	CcSEcCtD
Salmeterol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000405	CcSEcCtD
Salmeterol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000401	CcSEcCtD
Salmeterol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000393	CcSEcCtD
Salmeterol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000393	CcSEcCtD
Salmeterol—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00039	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000387	CcSEcCtD
Salmeterol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000385	CcSEcCtD
Salmeterol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000384	CcSEcCtD
Salmeterol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000384	CcSEcCtD
Salmeterol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000382	CcSEcCtD
Salmeterol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000381	CcSEcCtD
Salmeterol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000379	CcSEcCtD
Salmeterol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000374	CcSEcCtD
Salmeterol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000366	CcSEcCtD
Salmeterol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000363	CcSEcCtD
Salmeterol—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000363	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000358	CcSEcCtD
Salmeterol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000355	CcSEcCtD
Salmeterol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000353	CcSEcCtD
Salmeterol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00035	CcSEcCtD
Salmeterol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00035	CcSEcCtD
Salmeterol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000347	CcSEcCtD
Salmeterol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000346	CcSEcCtD
Salmeterol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000339	CcSEcCtD
Salmeterol—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.76e-05	0.000337	CcSEcCtD
Salmeterol—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000336	CcSEcCtD
Salmeterol—Pain—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000336	CcSEcCtD
Salmeterol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000336	CcSEcCtD
Salmeterol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000336	CcSEcCtD
Salmeterol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.37e-05	0.000324	CcSEcCtD
Salmeterol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.3e-05	0.000321	CcSEcCtD
Salmeterol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000313	CcSEcCtD
Salmeterol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000312	CcSEcCtD
Salmeterol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000311	CcSEcCtD
Salmeterol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000311	CcSEcCtD
Salmeterol—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.82e-05	0.000305	CcSEcCtD
Salmeterol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000291	CcSEcCtD
Salmeterol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.00029	CcSEcCtD
Salmeterol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.16e-05	0.000282	CcSEcCtD
Salmeterol—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000281	CcSEcCtD
Salmeterol—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.00027	CcSEcCtD
Salmeterol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000269	CcSEcCtD
Salmeterol—Rash—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000268	CcSEcCtD
Salmeterol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.74e-05	0.000268	CcSEcCtD
Salmeterol—Headache—Epirubicin—peripheral nervous system neoplasm	7.7e-05	0.000266	CcSEcCtD
Salmeterol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.00026	CcSEcCtD
Salmeterol—Nausea—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000252	CcSEcCtD
Salmeterol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.00025	CcSEcCtD
Salmeterol—Rash—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000248	CcSEcCtD
Salmeterol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.16e-05	0.000248	CcSEcCtD
Salmeterol—Headache—Doxorubicin—peripheral nervous system neoplasm	7.12e-05	0.000246	CcSEcCtD
Salmeterol—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000233	CcSEcCtD
